Neuren Pharmaceuticals Limited's total assets for Q2 2025 were AU$331.25M, a decrease of -19.15% from the previous quarter. NURPF total liabilities were AU$7.98M for the fiscal quarter, a -82.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.